Key Event: Outcome of Postal Ballot

The shareholders of Parnax Lab Ltd, through a remote e-voting (postal ballot) process, approved a special resolution. The voting period commenced on Friday, July 10, 2026, and concluded on Saturday, August 8, 2026. The date of the passing of the shareholders' resolution is deemed to be August 8, 2026.

Approved Resolution Details

  • Special Resolution: Re-appointment of Mr. Yogesh Kantilal Varia (DIN: 09186184) as a Non-Executive & Independent Director of the company.
  • Term: A second term of five consecutive years.
  • Tenure: Effective from May 28, 2026, to May 27, 2031.
  • Retirement: The director is not liable to retire by rotation.

Director Profile and Disclosures (Annexure L)

1. Name: Mr. Yogesh Kantilal Varia

2. DIN: 09186184

3. Date of Birth / Age: June 2, 1954 / 72 years

4. Reason for Change: Re-appointment

5. Date of Re-appointment: May 28, 2026

6. Brief Profile: Mr. Varia has over 40 years of experience in pharmaceutical and cosmetics manufacturing. The disclosure states he is committed to harnessing the growth potential of the Parnax Lab Limited Group and is diligent in strategy, planning, deal evaluation, and structuring.

7. Relationships: Mr. Varia is not related to any other directors or Key Managerial Personnel (KMP) of the company.

8. Shareholding: Nil (including beneficial ownership) as of the date of the Postal Ballot Notice.

9. Other Directorships: Not Available (NA) as of the date of the Postal Ballot Notice.

10. Committee Memberships: Not Available (NA) as of the date of the Postal Ballot Notice.

11. Resignations: Not Available (NA) for listed entities in the past three years.

Company and Contact Information

  • Factory Locations: Plot No. 120, 121 & 74, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-396230 (India)
  • Company Secretary & Compliance Officer: Preet Kukreja (ACS No.: 56761)
  • Date of Letter: August 10, 2026

Additional Information

The outcome of the postal ballot and the detailed disclosure (Annexure L) are also available on the company's website at www.naxparlab.com.